Kemwell AB of Sweden to double contract manufacturing for pharma industry

Uppsala, Sweden-based Kemwell AB plans to double its production area for contract manufacturing of pharmaceutical for drugmakers in the USA, European Union and Japan, claiming to already provide services to global majors such as GlaxoSmithKline, Johnson & Johnson, Novartis and Pfizer.

The Indian family owned company Kemwell Pvt Ltd acquired one of Pfizer's factories in Sweden during 2006 and by this transaction established itself as a contract manufacturer in the EU market. As a result of strong company development, Kemwell has now decided to increase its capacity by expanding the production area from 16,000 to 31,000 square meters. The expansion not only makes it possible for the company to increase production of tablets, suppositories and capsules but will also allow it to expand into other product types.

'Our new pharmaceutical factory will be characterized by a high degree of automatization and flexibility in order to satisfy the high demands of our existing and future clients within the pharmaceutical business,' noted Agneta Bergvall, chief executive of the Swedish unit. The new facilities also allow for production of other formulations. The company expects production in the new facility to start during 2010, she said.